Trypan Blue Exclusion Test of Cell Viability
Current Protocols in Immunology · 2015-11 · 111 (1)
DOI: 10.1002/0471142735.ima03bs111 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Protocols in Immunology, online erschienen am 02.11.2015. Verfasst von Warren Strober. Beteiligte Einrichtung: National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland. Hauptthemen laut MEDLINE: Cell Survival. Die Arbeit wurde bisher 1118-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS.
Abstract (Originalsprache)
The protocol described in this appendix allows for light microscopic quantitation of cell viability. Cells are suspended in PBS containing trypan blue and then examined to determine the percentage of cells that have clear cytoplasm (viable cells) versus cells that have blue cytoplasm (nonviable cells). © 2015 by John Wiley & Sons, Inc.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland.
Förderung
- Intramural NIH HHS
Zitieren
APA
Strober, W. (2015). Trypan Blue Exclusion Test of Cell Viability. Current Protocols in Immunology, 111(1). https://doi.org/10.1002/0471142735.ima03bs111
Vancouver
Strober W. Trypan Blue Exclusion Test of Cell Viability. Current Protocols in Immunology. 2015;111(1). doi:10.1002/0471142735.ima03bs111
BibTeX
@article{Strober2015,
author = {Strober, Warren},
title = {Trypan Blue Exclusion Test of Cell Viability},
journal = {Current Protocols in Immunology},
year = {2015},
volume = {111},
number = {1},
doi = {10.1002/0471142735.ima03bs111}
}
EUVIMED